欧洲药代动力学服务市场预测至 2031 年 - 区域分析 - 按药物类型（小分子、大分子和疫苗）、服务类型（临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等）、治疗应用（肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等）和最终用户（制药和生物技术公司、合同研究组织等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)

No. of Pages: 87    |    Report Code: BMIRE00030902    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Pharmacokinetics Services Market
Free Sample Buy Now
2023 年欧洲药代动力学服务市场价值为 2.2216 亿美元，预计到 2031 年将达到 3.8738 亿美元；预计 2023 年至 2031 年的复合年增长率为 7.2%。

将药代动力学服务外包给 CRO 推动欧洲药代动力学服务市场发展

将药代动力学服务外包给合同研究组织 (CRO) 为药品制造商和赞助商提供了多种优势。通过选择这些服务，他们可以经济高效地运营。此外，他们可以专注于灵活工作并为其核心业务带来可扩展性，同时实现快速的周转时间。外包有助于制药公司专注于产品商业化，同时实施能力建设、降低成本和数据管理措施。药物发现过程很复杂，任何错误或错误结果都可能导致重大成本并延迟该过程。 CRO 雇用经验丰富的科学家和研究人员，他们在药代动力学和其他领域拥有专业知识。因此，他们为制药公司提供了获取专业知识的机会，从而无需投资雇用此类熟练劳动力或提供额外培训来培养他们。因此，拥有有前途的候选药物但资源有限的小公司和涉及业务多元化的大公司都选择由组织良好的 CRO 提供的临床研究服务，这促进了欧洲药代动力学服务市场的发展。

欧洲药代动力学服务市场概览

欧洲药代动力学服务市场分为德国、法国、英国、西班牙、意大利和欧洲其他地区。预计德国和意大利等国家将占该地区市场的重要份额，而法国、英国和西班牙等国家可能会有药代动力学服务的增长机会。随着新药开发临床试验数量的增加，以及用于了解药代动力学变异性的体内和体外模型的日益普及，欧洲药代动力学服务市场预计在未来几年将实现增长。

欧洲药代动力学服务市场收入及预测至 2031 年（百万美元）

欧洲药代动力学服务市场细分

欧洲药代动力学服务市场分为药物类型、服务类型、治疗应用、最终用户和国家。

根据药物类型，欧洲药代动力学服务市场分为小分子、大分子和疫苗。小分子部分在 2023 年占据了最大的市场份额。

就服务类型而言，欧洲药代动力学服务市场分为临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等。 2023 年，临床前 ADME 和人体研究部门占据了最大的市场份额。

按治疗应用划分，欧洲药代动力学服务市场细分为肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等。2023 年，肿瘤学部门占据了最大的市场份额。

按最终用户划分，欧洲药代动力学服务市场细分为制药和生物技术公司、合同研究组织等。2023 年，合同研究组织部门占据了最大的市场份额。

按国家划分，欧洲药代动力学服务市场细分为德国、法国、英国、意大利、西班牙和欧洲其他地区。2023 年，法国占据了欧洲药代动力学服务市场份额的主导地位。

Charles River Laboratories International Inc；Eurofins Scientific SE；Evotec SE；Certara Inc.；Parexel International Corp； Thermo Fisher Scientific Inc.、Allucent、PACIFIC BIOLABS 和 SGS SA 是欧洲药代动力学服务市场的一些领先公司。

Europe Pharmacokinetics Services Strategic Insights

Strategic insights for Europe Pharmacokinetics Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-pharmacokinetics-services-market-strategic-framework.webp
Get more information on this report

Europe Pharmacokinetics Services Report Scope

Report Attribute Details
Market size in 2023 US$ 222.16 Million
Market Size by 2031 US$ 387.38 Million
Global CAGR (2023 - 2031) 7.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类型
  • 小分子
  • 大分子
  • 疫苗
By 服务类型
  • 临床前 ADME 和人体研究
  • PK/PD 分析和报告
  • 剂量模拟
  • 风险分析
By 最终用户
  • 制药和生物技术公司
  • 合同研究组织
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Allucent
  • Certara Inc.
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Evotec SE
  • PACIFIC BIOLABS
  • Parexel International Corp
  • SGS SA
  • Thermo Fisher Scientific Inc.
    		•
    Get more information on this report

    Europe Pharmacokinetics Services Regional Insights

    The regional scope of Europe Pharmacokinetics Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-pharmacokinetics-services-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Europe Pharmacokinetics Services Market

    1. Allucent
    2. Certara Inc.
    3. Charles River Laboratories International Inc
    4. Eurofins Scientific SE
    5. Evotec SE
    6. PACIFIC BIOLABS
    7. Parexel International Corp
    8. SGS SA
    9. Thermo Fisher Scientific Inc.
    Frequently Asked Questions
    How big is the Europe Pharmacokinetics Services Market?

    The Europe Pharmacokinetics Services Market is valued at US$ 222.16 Million in 2023, it is projected to reach US$ 387.38 Million by 2031.

    What is the CAGR for Europe Pharmacokinetics Services Market by (2023 - 2031)?

    As per our report Europe Pharmacokinetics Services Market, the market size is valued at US$ 222.16 Million in 2023, projecting it to reach US$ 387.38 Million by 2031. This translates to a CAGR of approximately 7.2% during the forecast period.

    What segments are covered in this report?

    The Europe Pharmacokinetics Services Market report typically cover these key segments-

  • 药物类型 (小分子, 大分子, 疫苗)
  • 服务类型 (临床前 ADME 和人体研究, PK/PD 分析和报告, 剂量模拟, 风险分析)
  • 最终用户 (制药和生物技术公司, 合同研究组织)

    • What is the historic period, base year, and forecast period taken for Europe Pharmacokinetics Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Pharmacokinetics Services Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Europe Pharmacokinetics Services Market?

    The Europe Pharmacokinetics Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Allucent
  • Certara Inc.
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Evotec SE
  • PACIFIC BIOLABS
  • Parexel International Corp
  • SGS SA
  • Thermo Fisher Scientific Inc.
    • Who should buy this report?

    The Europe Pharmacokinetics Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Pharmacokinetics Services Market value chain can benefit from the information contained in a comprehensive market report.

    europe-pharmacokinetics-services-market